Advanced search
Publication Cover
Blood Pressure Volume 11, 2002 - Issue 2
Submit an article Journal homepage
41
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Plasma Atrial Natriuretic Peptide in Essential Hypertension after Treatment with Irbesartan

Panagiotis Kotridis From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Basile Kokkas From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Michalis Karamouzis From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
George Sakadamis From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Ioannis Kanonidis From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
George Dadous From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Chrisoula Karantona From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Olga Gouli From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Joshef Karadoumanis From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
,
Pavlos C. Papadopoulos From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
&
Constantine L. Papadopoulos From the Departments of Second Cardiology, Pharmacology and Biochemistry, Medical School, Aristotle University of Thesssaloniki, Greece
 show all
Pages 91-94 | Published online: 08 Jul 2009

  • Papadopoulos CL, Kokkas B, Kotridis P, et al. Plasma atrial natriuretic peptide in essential hypertension after angiotensin converting enzyme inhibition. Int J Angiol 1995; 4: 44-5.
  • Papadopoulos CL, Kokkas B, Kotridis P, et al. The effect of /3rblocker bisoprolol on atrial natriuretic peptide plasma levels in hypertensive patients. Int J Angiol 1995; 4: 165-8.
  • Papadopoulos CL, Kokkas B, Kotridis P, et al. The effect of ß1-blocker/ß2-agonist celiprolol on atrial natriuretic peptide plasma levels in hypertensive patients. Cardiovasc Drugs Ther 1998; 12: 345-6.
  • Papadopoulos CL, Kokkas B, Anogiannakis G. Bta blockers and atrial natriuretic peptide (ANP) in hypertension. Int J Immunopathol Pharmacol 2000; 13: 107-10.
  • Gillis J, Markham A. Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs 1997; 54: 885-902.
  • Kama J, Nagata S, Takenaka T, et al. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients. Angiology 1995; 46: 511-6.
  • Kokkas B, Kotridis P, Karamouzis M, et al. Plasma atrial natriuretic peptide levels in essential hypertension after treatment with verapamil. Eur J Drug Metab Pharmacokin, in press.
  • Iwasaki T, Niwa A, Shinoda T, et al. Effects of calcium antagonists and nitroglycerin on atrial natriuretic peptide in normal subjects and patients with essential hypertension. Angiology 1989; 40: 24-8.
  • Hollenberg M, Plum J, Heering P, et al. Influence of betaxolol on renal function and atrial natriuretic peptide in essential hypertension. J Hypertension 1991; 9: 819-24.
  • Rosmalen F, Herman J, Tan A, et al. A sensitive radioimmunoassay of atrial natriuretic peptide in human plasma; some guidelines for clinical applications. Z Kardiol 1988; 77 Suppl 2: 20-5.
  • Karamouzis M, Mandroukas K, Deligiannis D, et al. Changes in atrial natriuretic peptide (a-ANP) in long distance swimmers. CHn Chem Enzym Commun 1994; 6: 191-5.
  • Conn J, Tognoni G. Effect of the angiotensin receptor blocker valsartan on morbidity and mortality in heart failure: the valsartan heart failure trial. Circulation 2000; 102: November 21, abstract
  • Liu y, Yang X, Sharov V, et al. Effects of angiotensinconverting enzyme inhibitors and angiotensin II type I receptor antagonists in rats with heart failure. J Clin Invest 1997; 99: 1926-35.
  • Pitt B, Segal R, Martinez F, et al. Randomized trial of losartan versus catopril in patients over 65 with heart failure. Lancet 1997; 349: 747-52.
  • Kirn S, Zhan Y, Izumi Y, Iwao H. Cardiovascular effects of combination of perindopril, candesartan and amlodipine in hypertensive rats. Hypertension 2000; 35: 769-74.
  • Magga J, Kalliovalkama J, Romppanen H, et al. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by ATI receptor antagonism and ACE inhibition in normotensive and hypertensive rats. J Hypertens 1999; 17: 1543-52.
  • YosWmoto T, Naruse M, Naruse K, et al. Angiotensin IIdepended down regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats. Endocrinology 1996; 137: 1102-7.
  • Guyton A, Hall J. Textbook of medical physiology. Philadelphia: W. B. Saunders, 1996: 373.
  • Raine A, Erne E, Burgisser F, et al. Atrial natriuretic factor and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533-9.
  • Guyton A, Gall T, Coleman T, et al. The dominant role of the kidneys in the long term regulation of arterial pressure in normal and hypertensive states. In: Laragh J, Brenner B, editors. Hypertension. New York: Raven Press, 1990:102952.
  • Yamakawa H, Imamura T, Matsuo T, et al. Diastolic wall stress and ang II in cardiac hypertrophy and gene expression induced by volume overload. Am J Physiol Heart Circ Physiol 2000; 279: H2939-46.
  • Volpe M, MeIe A, Indolfl C, et al. Hemodynamic and hormonal effects of atrial natriuretic factor in patients with essential hypertension. JACC 1987; 10: 787-93.
  • Marks E, Zukowsta-Grojec Z, Topchak T, et al. Alterations in systemic hemodynamics induced by atriopeptin III. J Hypertension 1987; 5: 39-46.
  • Lappe R, Smits J, TaIt J, et al. Faillure of atriopeptin II to cause arterial vasodilatation in the conscious rat Circ Res 1985;56:606-12.
  • Pegram B, Trippodo N, Natsume I, et al. Hemodynamic effects of atrial natriuretic hormone. Fed Proc 1986; 45: 2382-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.